
==== Front
Nat Commun
Nat Commun
Nature Communications
2041-1723
Nature Publishing Group UK London

38858379
49330
10.1038/s41467-024-49330-w
Author Correction
Author Correction: Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis
Zhang Zhenlei 1
Wu Yufan 1
Fu Jinrong 2
Yu Xiujie 3
Su Yang 4
Jia Shikai 1
Cheng Huili 1
Shen Yan 3
He Xianghui 5
Ren Kai 6
Zheng Xiangqian 7
http://orcid.org/0000-0003-3155-2847
Guan Haixia guanhaixia@gdph.org.cn

2
http://orcid.org/0000-0002-6038-6406
Rao Feng raof@sustech.edu.cn

4
http://orcid.org/0000-0002-1378-7434
Zhao Li shzhaoli@tmu.edu.cn

8
1 grid.265021.2 0000 0000 9792 1228 Department of Thyroid and Neck Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Clinical Research Center for Cancer, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
2 grid.284723.8 0000 0000 8877 7471 Department of Endocrinology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong China
3 https://ror.org/02ke5vh78 grid.410626.7 0000 0004 1798 9265 Department of Pathology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin, China
4 https://ror.org/049tv2d57 grid.263817.9 0000 0004 1773 1790 School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong China
5 grid.265021.2 0000 0000 9792 1228 Department of General Surgery, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China
6 https://ror.org/0152hn881 grid.411918.4 0000 0004 1798 6427 Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7 https://ror.org/0152hn881 grid.411918.4 0000 0004 1798 6427 Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
8 Department of Thyroid and Neck Tumor, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Clinical Research Center for Cancer, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
10 6 2024
10 6 2024
2024
15 4936© The Author(s) 2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Subject terms

Tumour biomarkers
Oncogenes
Ubiquitylation
Cell lineage
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcCorrection to: Nature Communications 10.1038/s41467-024-48173-9, published online 15 May 2024

In this article, the affiliation details for Li Zhao were incorrectly given as ‘Department of Thyroid and Neck Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Clinical Research Center for Cancer, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China’ but should have been ‘Department of Thyroid and Neck Tumor, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Clinical Research Center for Cancer, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China’. In addition, the affiliation details for Xiangqian Zheng were given incorrectly as ‘Department of Thyroid and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China.’ And should have been ‘Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China.
